Amit K. Sachdev
Senior Vice President, Public Policy and Government Affairs
Mr. Sachdev joined Vertex as Senior Vice President, Public Policy and Government Affairs, and is based in Washington D.C.
Mr. Sachdev came from Biotechnology Industry Organization (BIO) where he served as Executive Vice President, Health beginning in April 2005. At BIO, he was the senior executive responsible for managing BIO’s Health Section, its Governing Board, and for directing all health care policy and execution. Mr. Sachdev is the former Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he also held several other senior appointments from 2002 to 2005. At FDA, he oversaw the development of all FDA policies, regulations and legislation.
From 1998 to 2002, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives, where he was responsible for bioterrorism, food safety and environmental issues. Previously, from 1993 to 1997, Mr. Sachdev practiced law, first at the Chemical Manufacturers Association, and then with the law firm of Ropes and Gray. Mr. Sachdev received a B.S from Carnegie Mellon University, and a J.D. from the Emory University School of Law.
Amit K. Sachdev
Navigator
At Vertex, innovation is our lifeblood. It’s also a core value of the company. In order to deliver medical innovation to patients, we must be willing to take on great challenges, try new approaches, and navigate difficult or uncharted waters.
To succeed, we are committed to delivering the best science, and to do that we build highly talented research and development teams that attract others to invest in our mission. But we must also foster a regulatory and policy landscape that supports medical innovation and those who pursue it.
In this arena, rarely do we come across neutrality. Laws, regulations, policies, each present an opportunity to dramatically help or hinder our efforts. Leadership in public policy and government affairs is about identifying opportunities for collaboration, building lasting external alliances, and motivating and mobilizing people to take action to help us deliver breakthrough medicines to patients. Every interaction, whether it’s with a patient, a doctor, a global ambassador, a Member of Congress, or a regulatory official, is an opportunity to win support for our cause.